- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03623139
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education: A Randomized Controlled Trial Focusing on HbA1c and Glucose Variability in Patients With Type 2 Diabetes (The BCC Study)
The aim of the study is to examine the health benefits of adding a concept in basic carbohydrate counting (BCC) to the routine outpatient nutritional education for adult patients with type 2 diabetes.
The study hypothesis is that training and education in the BCC concept will improve glycaemic control either by reducing HbA1c or the average plasma glucose variability more than offering the routine dietary care as a stand-alone dietary treatment.
Study Overview
Status
Intervention / Treatment
Detailed Description
The trial has a parallel-group design with a study duration of 48 weeks for each participant (a 6-month intervention period and a 6-month follow-up period). A total of 226 patients will be enrolled in the trial. Participants will be randomized to one of two arms: 1) Standard medical and dietary care (control group) or 2) Structured training and education in the BCC concept in addition to standard medical and dietary care.
The primary objective is to evaluate the six months effect of structured training and education in the BCC concept compared to standard dietary care on glycaemic control as assessed by HbA1c or MAGE (mean amplitude of glycaemic excursions).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Bettina Ewers, MSc
- Phone Number: +45 30912997
- Email: bettina.ewers@regionh.dk
Study Contact Backup
- Name: Tina Vilsboell, DMSc
- Email: tina.vilsboell.lauritsen.01@regionh.dk
Study Locations
-
-
-
Herlev, Denmark, DK-2730
- Steno Diabetes Center Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Type 2 diabetes
- Diabetes duration; from >12 months
- HbA1c between 53 and 97 mmol/mol
- Diet or any glucose-lowering medication
- Provided voluntary written informed consent
Exclusion Criteria:
- Practicing carbohydrate counting, as judged by the investigator
- Participated in a BCC group program within the last two years
- Low daily intake of carbohydrates (defined as below 25 E% or 100 g/day), as judged by the investigator
- Use of open CGM
- Use of a Free Libre device
- Use of an automated bolus calculator for carbohydrate counting, as judged by the investigator
- Gastroparesis
- Pregnancy or breastfeeding, or plans of pregnancy within the study period
- Uncontrolled medical issues, as judged by the investigator
- Concomitant participation in other clinical studies
- Unable to understand the informed consent and the study procedures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard nutritional education
Control group
|
Routine dietary care consists of three individual consultations with a trained dietitian.
The individual guidance will be in accordance with the dietary guidelines in type 2 diabetes.
Other Names:
|
Experimental: BCC
Education and training i basic carbohydrate counting (BCC) plus standard nutritional education
|
The BCC concept is a group-based program consisting of three group sessions delivered by trained dietitians.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HbA1c
Time Frame: Baseline, 6 months
|
mmol/mol
|
Baseline, 6 months
|
Change in mean amplitude of glycaemic excursions (MAGE)
Time Frame: Baseline, 6 months
|
mmol/l
|
Baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HbA1c
Time Frame: 12 months
|
mmol/mol
|
12 months
|
Change in body weight
Time Frame: Baseline, 6 months, 12 months
|
kg
|
Baseline, 6 months, 12 months
|
Change in low-density lipoprotein cholesterol (LDL-C)
Time Frame: Baseline, 6 months, 12 months
|
mmol/l
|
Baseline, 6 months, 12 months
|
Change in high-density cholesterol (HDL-C)
Time Frame: Baseline, 6 months, 12 months
|
mmol/l
|
Baseline, 6 months, 12 months
|
Change in total cholesterol (TC)
Time Frame: Baseline, 6 months, 12 months
|
mmol/l
|
Baseline, 6 months, 12 months
|
Change in free fatty acids (FFA)
Time Frame: Baseline, 6 months, 12 months
|
mmol/l
|
Baseline, 6 months, 12 months
|
Change in triglycerides (TG)
Time Frame: Baseline, 6 months, 12 months
|
mmol/l
|
Baseline, 6 months, 12 months
|
Change in diastolic blood pressure
Time Frame: Baseline, 6 months, 12 months
|
mm Hg
|
Baseline, 6 months, 12 months
|
Change in systolic blood pressure
Time Frame: Baseline, 6 months, 12 months
|
mm Hg
|
Baseline, 6 months, 12 months
|
Change in waist circumference
Time Frame: Baseline, 6 months, 12 months
|
cm
|
Baseline, 6 months, 12 months
|
Change in hip circumference
Time Frame: Baseline, 6 months, 12 months
|
cm
|
Baseline, 6 months, 12 months
|
Change in total fat free mass
Time Frame: Baseline, 6 months
|
gram
|
Baseline, 6 months
|
Change in total fat mass
Time Frame: Baseline, 6 months
|
gram
|
Baseline, 6 months
|
Change in time in range (3.9-10.0 mmol/l)
Time Frame: Baseline, 6 months
|
percent (%)
|
Baseline, 6 months
|
Changes in time spent in hypoglycaemia (<3.9 mmol/l)
Time Frame: Baseline, 6 months
|
percent (%)
|
Baseline, 6 months
|
Change time spent in hyperglycaemia (e.g. >11.1 mmol/l)
Time Frame: Baseline, 6 months
|
percent (%)
|
Baseline, 6 months
|
Change in standard deviation of mean plasma glucose
Time Frame: Baseline, 6 months
|
mmol/l
|
Baseline, 6 months
|
Change in mathematical literacy
Time Frame: Baseline, 6 months, 12 months
|
total score or percent (%)
|
Baseline, 6 months, 12 months
|
Change in carbohydrate estimation accuracy
Time Frame: Baseline, 6 months, 12 months
|
total score or %
|
Baseline, 6 months, 12 months
|
Change in diet-related quality of life
Time Frame: Baseline, 6 months, 12 months
|
total score or percent (%)
|
Baseline, 6 months, 12 months
|
Change in perceived competences in diabetes
Time Frame: Baseline, 6 months, 12 months
|
total score or percent (%)
|
Baseline, 6 months, 12 months
|
Change in degree of autonomy-supportive dietitian
Time Frame: Baseline, 6 months, 12 months
|
total score or percent (%)
|
Baseline, 6 months, 12 months
|
Change in total energy intake
Time Frame: Baseline, 6 months
|
kJ/day
|
Baseline, 6 months
|
Change in dietary intake of carbohydrates
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of total fat
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of saturated fatty acids (SFA)
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of monounsaturated fatty acids (MUFA)
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of polyunsaturated fatty acids (PUFA)
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of protein
Time Frame: Baseline, 6 months
|
gram/day or percent of total energy (E%)
|
Baseline, 6 months
|
Change in dietary intake of added sugar
Time Frame: Baseline, 6 months
|
gram/day , % of total energy or %
|
Baseline, 6 months
|
Change in intake of dietary fibre
Time Frame: Baseline, 6 months
|
gram/day or g/MJ
|
Baseline, 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical activity level
Time Frame: Baseline, 6 months, 12 months
|
total score or percent (%)
|
Baseline, 6 months, 12 months
|
Change in urinary biomarkers of carbohydrate intake
Time Frame: Baseline, 6 months
|
percent (%)
|
Baseline, 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Bettina Ewers, MSc, Steno Diabetes Center Copenhagen
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-18014918
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Solvay PharmaceuticalsTerminatedDyslipidemia | Glucose Metabolism DisorderPoland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderCzech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
Clinical Trials on Standard nutritional education
-
Instituto Nacional de Ciencias Medicas y Nutricion...RecruitingHemodialysis | Peritoneal Dialysis | Nutritional Status | Chronic Kidney Disease | Predialysis | Adherence | Educational ActivitiesMexico
-
Taipei Medical UniversityMeiji Co., Ltd.CompletedMalnutrition ElderlyTaiwan
-
Abbott NutritionWithdrawn
-
Hospital El EscorialUnknownADHD | Food Habits | Lifestyle-Related ConditionSpain
-
Federal University of Rio Grande do SulCompleted
-
Coordinación de Investigación en Salud, MexicoNational Council of Science and Technology, MexicoCompleted
-
Boston UniversityCompleted
-
Oregon Health and Science UniversityWithdrawnPregnancy RelatedUnited States
-
Diana Avila MontielNot yet recruitingOverweight and Obesity | Malnutrition, Child
-
Selcuk UniversityEnrolling by invitationFood Safety, Security and Waste Prevention Intervention on the KAB-P Approach of University StudentsEducational ProblemsTurkey